Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 5, 2008, Pages 520-522

  Rebbapragada, Anuradha ^a   Howe, Kathryn ^a   Wachihi, Charles ^b   Pettengell, Christopher ^a   Sunderji, Sherzana ^a   Huibner, Sanja ^a   Ball, T Blake ^c   Plummer, Francis A ^c   Jaoko, Walter ^b   Kaul, Rupert ^a,b,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e #6356 Medical Sciences Building ^*  (Canada)

Author keywords

Altered vaginal flora; Bacterial vaginosis; Genital tract; HIV; Inflammation; Mucosal immunology; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; CD69 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; METRONIDAZOLE; RANTES; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FEMALE SEX WORKER; FEMALE WORKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; KENYA; MUCOSAL IMMUNITY; PRIORITY JOURNAL; PROSTITUTION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY; VAGINA FLORA; VAGINITIS; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION; CD4 LYMPHOCYTE COUNT; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY;

ANTI-BACTERIAL AGENTS; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; CHEMOKINE CCL5; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; METRONIDAZOLE; VAGINOSIS, BACTERIAL; VIRUS SHEDDING;

EID: 62749093768     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318189a7ca     Document Type: Article

References (13)

1. Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol. 2008;77:32-40.
2. Schwebke JR. Role of vaginal flora as a barrier to HIV acquisition. Curr Infect Dis Rep. 2001;3:152-155.
3. Eschenbach DA, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988;158: 819-828.
4. Hedges SR, Barrientes F, Desmond RA, et al. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis. 2006;193: 556-562.
5. Al-Harthi L, Roebuck KA, Olinger GG, et al. Bacterial vaginosisassociated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr. 1999;21:194-202.
6. Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37:319-325.
7. Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007;196:1692-1697.
8. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. AIDS. 2007;21:589-598.
9. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.
10. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005;5:783-792.
11. Spear GT, St John EP, Zariffard MR. Bacterial vaginosis and human immunodeficiency virus infection. AIDS Res Ther. 2007;4:25.
12. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies. AIDS. 2008;22:1493-1501.
13. Hladik F, Sakchalathom P, Ballweber L, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007;26:257-270.